alexa Activation Of NLRP3-inflammasome In Human Monocyte-derived Macrophages Infected With Mycobacterium Spp
ISSN: 1745-7580

Immunome Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

8th Molecular Immunology and Immunogenetics Congress
March 20-21, 2017 Rome, Italy

Dhemerson Souza de Lima, Eduardo Pinheiro Amaral, Mauricio Morishi Ogusku, Aya Sadahiro and Alessandra Pontillo
University of São Paulo, Brazil
National Institutes of Health, USA
National Institute of Amazonian Research, Brazil
Federal University of Amazonas, Brazil
Posters & Accepted Abstracts: J Immunome Res
DOI: 10.4172/1745-7580.C1.012
Statement of the Problem: Tuberculosis (TB) is still a major public health problem worldwide, and it is estimated that 1/3 of world population could be latently infected by Mycobacterium spp. Active TB represents a big challenge for treatment due to the natural resistance of bacteria to common antibiotics, and to the emergence of multidrug resistant strains. The development of active disease results from the host inability to effectively counteract the bacteria. In this context, both innate and acquired immunity have been taken in account as important factors for protection against TB. Nod like receptors (NLRs) and the cytoplasmic complex known as inflammasome are responsible for caspase-1 activation and the consequent production of active form of the pro-inflammatory cytokines IL-1ß and IL-18. Experimental models have showed that M. tuberculosis activates NLRP3-inflammasome and IL-1ß production. Aim of this project is to evaluate the contribution of inflammasome in human TB. Methodology & Theoretical Orientation: The distribution of 14 single polymorphisms (SNPs) in 9 selected inflammasome genes was evaluated in a case/control cohort of Amazon TB patients (allele-specific Taqman assays and qPCR). Inflammasome activation was then analyzed in human peripheral blood monocytes-derived macrophages (MDM) stimulated with M. tuberculosis (BCG or H37Rv) by the meaning of IL-1β and IL-18 production (ELISA), gene expression modulation (gene-specific Taqman assays and qPCR). Experiments were done in the presence of common NLRP3 inflammasome activators (ATP, LPS), or inhibitors (parthenolide). Conclusion & Significance: Polymorphisms in inflammasome genes contributes to control (NLRP3, CTSB) or development (P2X7) of active pulmonary TB. M. tuberculosis induced dramatic release of IL-1β and IL-18 from MDM, and the increase of NLRP3, IL1B and IL18 genes expression, suggesting that both indirect (through NF-kB) and direct (through caspase-1) activation of inflammasome are involved in the response. Preliminary data showed that this activation is significantly inhibited by parthenolide, confirming the involvement of inflammasome in response to M tuberculosis in human MDM. Associated SNPs positively correlated with IL-1ß and/ or IL-18 production in MDM. Further experiments are going on to fully elucidate the contribution of inflammasome in TB.

Dhêmerson Souza de Lima has expertise in evaluation molecular biology with the emphasis on immunology, working mainly on the following topics: tuberculosis, immunogenetics of pulmonary tuberculosis, and HLA class II and inflammasome genetics and the response immune to Mycobacterium spp. Recently he was reported that HLA-DRB1*04 gene and subtypes associated with pulmonary tuberculosis in Amazon Brazilian, and may be potential immunogenetic markers involved in disease. Besides, he found that NLRP3-inflammasome genetics seems to be protective against the development active pulmonary tuberculosis, however, P2X7 is associated with increased susceptibility. Currently is Ph.D. student in work with innate immune response and pathway to activation inflammasome.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materials[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version